Table of Contents
An Innsbrook company announced Monday that it will begin shipping at least 800 COVID-19 tests daily to testing sites and will be able to increase capacity to 5,000 tests per day and as many as 150,000 per month beginning in April. GENETWORx officials said the company will have the ability to to provide results within 24 hours of receiving samples.
GENETWORx is working within the emergency use authorization guidelines from the United States Food and Drug Administration to specifically conduct COVID-19 testing, officials said. The company is a CLIA-certified laboratory owned by Recovery Centers of America.
GENETWORx conducts a variety of molecular laboratory diagnostic and clinical testing services but has repurposed a portion of its lab so that rapid analysis of COVID-19 samples can be performed in response to the national need.
"We want to do our part in contributing our expertise to help in the nation's battle against the coronavirus,” said William Miller, the company’s CEO. “The technology we have developed not only allows us to mass produce these much needed COVID-19 tests but also ensures an accurate test result in a timely 24-hour response time from receipt of the sample.”
